View Older Stories View More Recent Stories
-
Vital Farms Announces Pricing of Secondary Public Offering of Common Stock at Closing Market Price
-
Vital Farms Announces Pricing of Secondary Public Offering of Common Stock at Closing Market Price
-
Telos Corporation Announces Launch of IPO
-
Aurora Cannabis (ACB) Prices $150 Million Underwritten Public Offering of Common Shares, Warrants
-
Aurora Cannabis Prices US$150 Million Underwritten Public Offering
-
Aurora Cannabis Prices US$150 Million Underwritten Public Offering
-
UPDATE: BMO Capital Upgrades Duke Realty (DRE) to Outperform (CORRECTION)
-
Wabash National (WNC) PT Raised to $16 at BMO Capital Following 3Q Beat
-
Sonoco Products (SON) PT Raised to $65 at BMO Capital Following News of Effective COVID Vaccine
-
UPDATE: BMO Capital Downgrades CIT Group (CIT) to Market Perform
-
Jadestone Energy Inc Announces Settlement in Respect of Vietnam Dispute
-
Datto Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Aurora Cannabis (ACB) Announces $125M Proposed Public Offering
-
Aurora Cannabis Announces Proposed Public Offering
-
Aurora Cannabis Announces Proposed Public Offering
-
Gatos Silver Announces Full Exercise of Underwriters’ Over-Allotment Option
-
BMO Commits $5 Billion to Advance Inclusive Economic Recovery in the U.S.
-
Brett Skolnik Joins Edgemont Partners as Managing Director in Healthcare Services
-
PIMCO Tactical Income Fund Announces Exercise of Over-Allotment Option
-
UPDATE: BMO Capital Upgrades The Chefs' Warehouse, Inc (CHEF) to Outperform
-
UPDATE: BMO Capital Upgrades Performance Food Group (PFGC) to Outperform
-
UPDATE: BMO Capital Upgrades Sysco (SYY) to Outperform
-
UPDATE: BMO Capital Upgrades US Foods (USFD) to Outperform
-
VEREIT® Announces Pricing of $1.2 Billion of Senior Notes
-
BMO Financial Group Announces Executive Appointments
-
Morphic Therapeutic (MORF) PT Raised to $40 at BMO Capital
-
Endo International plc (ENDP) PT Raised to $7 at BMO Capital
-
Retrophin (RTRX) PT Raised to $33 at BMO Capital
-
Match Group (MTCH) PT Raised to $130 at BMO Capital
-
Fate Therapeutics (FATE) PT Raised to $43 at BMO Capital
-
Yelp (YELP) PT Raised to $27 at BMO Capital
-
Replimune Group (REPL) PT Raised to $57 at BMO Capital
-
UPDATE: BMO Capital Downgrades bluebird bio (BLUE) to Market Perform
-
Canada's imports, exports rise in September; trade deficit widens
-
Dollarama Announces Chief Financial Officer Successor Appointment
-
Real Estate & E-Commerce Split Corp. Announces Exchange Ratios
-
Bank of Montreal to Redeem $1,000,000,000 3.34% Series H Medium-Term Notes Second Tranche (Non-Viability Contingent Capital (NVCC))
-
Scholar Rock Announces Closing of Public Offering of Common Stock and Prefunded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Horizon Therapeutics (HZNP) PT Raised to $110 at BMO Capital, Following Earnings
-
VBI Vaccines (VBIV) PT Lowered to $6 at BMO Capital
-
Dorel Reaches Agreement in Principle Regarding Potential Going-Private Transaction
-
UPDATE: BMO Capital Starts fuboTV (FUBO) at Outperform
-
Help at Home Acquired by Centerbridge Partners and The Vistria Group From Wellspring
-
Gatos Silver Announces Closing of Initial Public Offering
-
CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces PharmHouse Commencement of SISP
-
Yum! Brands (YUM) PT Raised to $100 at BMO Capital
-
Starbucks (SBUX) PT Raised to $93 at BMO Capital
-
Alphabet (GOOGL) PT Raised to $1,950 at BMO Capital
-
Facebook (FB) PT Lowered to $270 at BMO Capital
-
Dunkin' Brands (DNKN) PT Raised to $80 at BMO Capital

